Cargando…

ULK1 as a novel therapeutic target in neurodegeneration

Detalles Bibliográficos
Autores principales:	Vahsen, Björn Friedhelm, Lingor, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224110/ https://www.ncbi.nlm.nih.gov/pubmed/33269781 http://dx.doi.org/10.4103/1673-5374.300442

Ejemplares similares

AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
por: Ribas, Vinicius Toledo, et al.
Publicado: (2021)

Inhibition of the autophagic protein ULK1 attenuates axonal degeneration in vitro and in vivo, enhances translation, and modulates splicing
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
por: Holden, Joseph M., et al.
Publicado: (2022)

Synthetic cell pathobiology to study neurodegeneration: defining new therapeutic targets in astroglia
por: Stenovec, Matjaž, et al.
Publicado: (2016)

Oxidative stress in N88S seipinopathy: novel insights into the mechanisms of neurodegeneration and therapeutic avenues
por: Costa, Vítor, et al.
Publicado: (2022)

From adaption to death: endoplasmic reticulum stress as a novel target of selective neurodegeneration?
por: Liu, Yiting, et al.
Publicado: (2015)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

The incredible ULKs
por: Alers, Sebastian, et al.
Publicado: (2012)

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions
por: Iqbal, Khalid, et al.
Publicado: (2014)

Novel perspectives for neurodegeneration prevention: effects of bioactive polyphenols
por: Crispi, Stefania, et al.
Publicado: (2020)

Autophagy in degenerating axons following spinal cord injury: evidence for autophagosome biogenesis in retraction bulbs
por: Ribas, Vinicius T., et al.
Publicado: (2015)

Calcium channel inhibition-mediated axonal stabilization improves axonal regeneration after optic nerve crush
por: Ribas, Vinicius T., et al.
Publicado: (2016)

Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
por: Maass, Fabian, et al.
Publicado: (2018)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)

Nuclear peroxisome proliferator activated receptor-gamma (PPARγ) as a therapeutic target to treat neurodegeneration and dependence elicited by drugs of abuse
por: Ciccocioppo, Roberto, et al.
Publicado: (2020)

Central CB(2) receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
por: Concannon, Ruth M., et al.
Publicado: (2016)

Caspase-1: an important player and possible target for repair of the blood-brain barrier underlying neurodegeneration
por: Rand, Daniel, et al.
Publicado: (2021)

ER-Targeted Beclin 1 Supports Autophagosome Biogenesis in the Absence of ULK1 and ULK2 Kinases
por: Anwar, Tahira, et al.
Publicado: (2019)

SIGMAR1 Confers Innate Resilience against Neurodegeneration
por: Couly, Simon, et al.
Publicado: (2023)

ERp57 in neurodegeneration and regeneration
por: Bargsted, Leslie, et al.
Publicado: (2016)

Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023)

The local mammalian target of rapamycin (mTOR) modulation: a promising strategy to counteract neurodegeneration
por: Dolcetta, Diego, et al.
Publicado: (2019)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
por: Qiu, Xiaonan, et al.
Publicado: (2021)

Neurodegeneration in branch retinal vein occlusion
por: Alshareef, Rayan A., et al.
Publicado: (2016)

DNA damage and neurodegeneration: the unusual suspect
por: Stein, Daniel, et al.
Publicado: (2017)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

Mitochondrial bioenergetics and neurodegeneration: a paso doble
por: Rossi, Alice, et al.
Publicado: (2020)

The ingenious ULKs: expanding the repertoire of the ULK complex with phosphoproteomics
por: Mercer, Thomas J., et al.
Publicado: (2021)

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015)

Astrocytic Kir4.1 potassium channels as a novel therapeutic target for epilepsy and mood disorders
por: Ohno, Yukihiro
Publicado: (2018)

Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015)

Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
por: Silberman, Dafne M.
Publicado: (2018)

CD8(+) T cells in neurodegeneration: friend or foe?
por: Hu, Dan, et al.
Publicado: (2022)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

TFG: a novel regulator of ULK1-dependent autophagy
por: Cecconi, Francesco, et al.
Publicado: (2021)

Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration
por: Northrop, Amy, et al.
Publicado: (2020)

Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration
por: Hudobenko, Jacob, et al.
Publicado: (2023)

Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?
por: Angeloni, Cristina, et al.
Publicado: (2015)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_da2hkjd0a95657e14icfg9v1tq